Crossmark

Role of CD133 antibody-conjugated nanocarrier in enhancing the targetability of hepatocellular carcinoma stem cells

Crossref DOI link: https://doi.org/10.1038/s41598-025-14435-9

Published Online: 2025-08-19

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Aglan, Hadeer A. https://orcid.org/0000-0003-0837-0172
Abd-Rabou, Ahmed A. https://orcid.org/0000-0002-9875-7591
Ahmed, Hanaa H. https://orcid.org/0000-0001-8642-9251
Elsayed, Ghada H. https://orcid.org/0000-0002-5505-217X
Kishta, Mohamed S. https://orcid.org/0000-0002-2314-8820
Elhinnawi, Manar A. https://orcid.org/0000-0002-0061-9060
Mahmoud, Nadia S. https://orcid.org/0000-0002-9085-4063
Funding

Funding for this research was provided by:

National Research Centre Egypt
License Information

Text and Data Mining valid from 2025-08-19

Version of Record valid from 2025-08-19
More Information

Article History

Received: 17 May 2025

Accepted: 31 July 2025

First Online: 19 August 2025

Declarations

:

: The authors declare no competing interests.